Track: 12

                        Pharmaceutical Regulatory Affairs

Drug Formulation Congress 2018 | Pharmaceutical Regulatory Affairs

Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the Regulatory Affairs’ department. Regulatory Affairs professionals can play a key role in guiding drug development strategy in an increasingly global environment. But they also play an important operational role, for example, by considering the best processes to follow and enabling structured interaction with regulatory authorities. Regulatory Affairs is driven by good science and accordingly nothing remains static.

• Regulatory Affairs for Clinical Trails
• Management of Quality Standards
• Regulatory Affairs Profession
• Regulatory Consulting & Market Analysis
• Quality Assurance in Regulatory Affairs
• Healthcare Regulatory Affairs
• Pharmaceutical Companies & Regulatory Guidelines

November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/  

Track: 11

                 Chemical and Pharmaceutical Engineering

 Drug Formulation Congress 2018 | Chemical and pharmaceutical Engineering

Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "pharmaceutical engineering" has only emerged recently as a divergent engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.

• Pharmaceutical Engineering
• Chemical Engineering Research
• Pharmaceutical Research & Development
• Technical Chemistry
• Biomedical Engineering

November 8-9

 

Submit  related to above track in link give below:

 https://drugformulation.pharmaceuticalconferences.com/abstract-submission.php

Track: 10

                       Drug Product Manufacturing 

Drug FormulationCongress 2018 | Drug Product Manufacturing

 

Drug manufacturing (Pharmaceutical Manufacturing) is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be demolished down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others. The changing pharmaceutical landscape is a popular discussion point as of late. Armed with a fresh, non-blockbuster business model and treatment options that are expanding from small molecules to a range of new, more targeted therapies, the industry is at what PwC calls, “a critical juncture.”

Parenteral drug delivery is the second largest segment of this transformative pharmaceutical market covered only by the more mature https://drugformulation.pharmaceuticalconferences.com/abstract-submission.php  accounting for nearly 30 percent of total pharma market share. According to Survey, the market for parenteral drug delivery  products is projected to rise over 10 percent annually to $86.5 billion in 2019.

• Unit operations
• Formulation & Pre-formulation Development
• Manufacturing Steps
• Ensuring that Products Meet Specifications 

 November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/

Track: 9

     Medicinal Chemistry and Drug Discover Advancements

Drug FormulationCongress 2018 | Medicinal Chemistry and Drug Discover Advancements

 Medicinal Chemistry is a branch of chemistry which especially agreements with synthetic organic chemistry and pharmacology including various other biological specialties which is involved with design, chemical reation and development of drug for marketing of pharmaceutical agents. It combines knowledge and capacities from the fields of cheminformatics, molecular modeling and important bioinformatics and demands an in-depth appreciative of the physico-chemical properties of a three-dimensional molecule. The information base required by today's medicinal chemist has increased dramatically and has highlighted an rising challenge for chemists to understand the growing field of drug design.

• Drug Delivery
• Drug Design
• Genomics & Proteomics
• Stem-cell Therapy, Vaccination, Gene Therapy
• Non-human Experimental Aspects
• Virtual Chemistry
• Clinical Chemistry & Laboratory Medicine
• Diagnostic Clinical Chemistry

November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/

Track: 8

                       Novel Drug Delivery System

Identifying drug targets plays essential roles in designing new drugs and combating diseases. Unfortunately, our current understanding about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for most important social and health affliction as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths worldwide. The lipid abnormality is one of the most important modifiable risk factors for atherosclerosis. Both genetic and environmental components are associated with the development of atherosclerotic plaques. Immune and inflammatory mediators have a complex role in the initiation and progression of atherosclerosis. Understanding of all these processes will help to invent a range of new biomarkers and novel treatment modalities targeting various cellular events in acute and chronic inflammation that are accountable for atherosclerosis. Several biochemical pathways, recetors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for disease diagnosis and management.

·         Smart Drug Delivery Technology

·         Design & Characterization of Nano Drug Systems

·         Design & Delivery of nano drug

·         Drug Delivery Carriers

·         Administration Routes

 November 08-09
For  more details: https://drugformulation.pharmaceuticalconferences.com/

 

Track: 7

           Innovative Drug Discovery and

       Nanotechnology

Drug Formulation Congress 2018 | Innovative Drug Discovery and Nanotechnology

Size reduction is a fundamental unit operation having important applications in pharmacy. It helps in improving solubility and bioavailability, reducing toxicity, enhancing release and providing better drug formulation opportunities for drugs. In most of the cases, size reduction is limited to micron size range, for example, various pharmaceutical dosage forms like powder, emulsion, suspension etc. Drugs in the nano meter size range enhance performance in a variety of dosage forms. Major advantages of nanosizing include (i) increased surface area, (ii) enhanced solubility, (iii) increased rate of dissolution, (iv) increased oral bioavailability, (v) more rapid onset of therapeutic action, (vi) less amount of dose required, (vii) decreased fed/fasted variability, and (viii) decreased patient-to-patient variability.

Pharmaceutical nanotechnology has provided more fine-tuned diagnosis and focused treatment of disease at a molecular level. Pharmaceutical nanotechnology is most innovative and highly specialized field, which will revolutionize the pharmaceutical industry in near future. Pharmaceutical nanotechnology presents revolutionary opportunities to fight against many diseases. It helps in detecting the antigen associated with diseases such as cancer, diabetes mellitus, neurodegenerative diseases, as well as detecting the microorganisms and viruses associated with infections. It is expected that in next 10 years market will be flooded with nanotechnology devised medicine.

• Nanometrology
• Nanotechnogy methods in Drug Design
• Nanotechnology Fundamental Concepts
• Nanomedicine
• Nano Science &Technology
• Nano Robotics
• Medical Applications in Nanotechnology

November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/ 

Track: 6

                            Clinical Trails & Biotherapeutics

Drug Formulation Congress 2018 | Clinical Trails & Biotherapeutics

 

Clinical Biotherapeutic aspects including study drug design, drug-drug interactions, QT assessment, immunogenicity, comparability, special populations (hepatic and liver failure), PK and PD, regulatory expectations of PK and PD characterization, as well as reviewing factors which influence the ADME of Biotherapeutics. The objectives of early clinical development of therapeutic proteins are the same as for small molecules i.e. to investigate the molecule in a manner that will gain necessary knowledge about its tolerability safety pharmacokinetics (PK) and if possible pharmacodynamics (PD) effects in the most appropriate human populations while simultaneously protecting their safety. However, there are specific features of proteins that must be considered when designing clinical pharmacology studies.

• Discovery & Preclinical Testing
• Clinical Study Designs
• Alternative Trials Design & Models
• Data Collection & Quality Control
• Advanced Information Technology in Clinical trials
• Clinical Trial Protocol
• Recent Technology in Biopharmaceuticals 

November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/